finance

Wanda Health Inc CEO Tom Smith visits the Proactive London studio to speak with Thomas Warner after the Remote Patient Monitoring (RPM) company announced the start of a new fundraise.Smith gives an overview of what Wanda intends to do with the proceeds, highlighting the company’s sharp focus on integrating Artificial Intelligence (AI) into its RPM solutions.The company has also appointed a new head of AI to oversee the development of disease-specific AI algorithms, focusing on readmission risk, social suitability, and insurer billing data integration into their platform.Smith goes on to say that Wanda Health is currently undergoing FDA approval for their congestive heart failure readmission risk models. These models aim to predict patient exacerbations and hospital admissions up to seven days in advance, providing healthcare providers with crucial data for early intervention.In addition to AI developments, Wanda Health has established a clinical outsourcing team to support primary care providers who are resource-constrained. This move not only improves patient outcomes but also boosts revenue for healthcare providers and Wanda Health. The company is also focusing on automated healthcare solutions, aiming to enhance patient triage and management while still valuing human intervention in healthcare.Wanda Health is backed by NetScientific PLC (AIM:NSCI).#WandaHealth #NetScientific #HealthcareInnovation #AIinHealthcare #RemotePatientMonitoring #FDAApproval #ArtificialIntelligence #HealthTech #DigitalHealth #CongestiveHeartFailure #HealthcareAI #MedicalTechnology #PatientMonitoring #ClinicalTrials #HealthcareManagement #HealthcareIndustry #TomSmithInterview #ProductiveLondon #HealthcareFunding #MedicalAI #HealthcareOutsourcing #HealthcareStrategy #HealthcareDevelopment #AIHealthcareSolutions #HealthcareTrends2023 #ProactiveInvestors #Wanda #RPM #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Flynn Gold Ltd (ASX:FG1) CEO Neil Marston speaks to Thomas Warner from Proactive after the exploration company announced it has secured a binding option agreement to acquire two exploration licences at Parker Dome, just 50 kilometres north of the world-class Mount Holland Lithium Project in Western Australia.Simultaneously, the company is raising A$2.4 million via a placement and share purchase plan (SPP) to further exploration activities at its West Australian and Tasmanian projects.Marston highlights the high potential for lithium and the company’s plan to explore the tenements before committing to a purchase. He says the acquisition, priced at around $500,000 in cash and script with additional deferred considerations, aligns well with Flynn Gold’s existing lithium projects.Historically, the focus on these tenements was gold, but recent shallow drilling revealed untapped lithium potential. The company plans fresh drilling in the new year to explore this further. Alongside this expansion, Flynn Gold is conducting a capital raise of $2.4 million, including a shareholder meeting scheduled for January.Looking ahead, Flynn Gold aims to start preliminary sampling at Parker Dome before Christmas and initiate drilling on identified targets post capital raising completion. Additionally, Marston shared updates on ongoing activities in Tasmania.#FlynnGoldLtd #NeilMarston #GoldExploration #LithiumMining #ParkerDomeProject #WesternAustraliaMining #ExplorationLicenses #MiningIndustry #CapitalRaise #DrillingUpdates #TasmaniaMining #MineralExploration #ResourceSector #MiningInvestment #CEOInterview #ProactivInterview #NaturalResources #MiningTechnology #GreenstoneBelt #ResourceDevelopment#ProactiveInvestors #gold #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews